Postmarketing surveillance of the safety of cimetidine

letter

. 1983 Jun 25;286(6383):2062. doi: 10.1136/bmj.286.6383.2062-a

Postmarketing surveillance of the safety of cimetidine.

PMCID: PMC1548514 PMID: 6409227

These references are in PubMed. This may not be the complete list of references from this article.

Behan P. O., Behan W. M., Zacharias F. J., Nicholls J. T. Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. Lancet. 1976 Nov 6;2(7993):984–987. doi: 10.1016/s0140-6736(76)90831-x. [DOI] [PubMed] [Google Scholar]